The global natural killer cells therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, natural killer cells are liable for generating immunoregulatory cytokines. Moreover, these cells act as a key component of the human body within the innate immune system. The key role of these cells is to produce a natural immune response against tumors and viral infections. In addition to this, natural killer cells play a pivotal role in tumor immune surveillance that encourages the adoption of natural killer therapeutics across the globe.
A full report of Natural Killer Cells Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/natural-killer-cells-therapeutics-market
The rise in the adoption of natural killer cells for the treatment of cancer, infections, and liver diseases is a key factor that drives the growth of the natural killer cells therapeutics market. Moreover, the rise in awareness among the population regarding various immunotherapies coupled with the surge in R&D for the development of bi-specific antibodies through natural killer cells to eradicate tumor cells propel the global market growth. For instance, in parallel with the AML trial, Glycostem will initiate a phase 2a trial to start testing oNKord in 14 patients with multiple myeloma, which will put Glycostem on track to file for conditional approval of oNKord in two indications in 2023.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/natural-killer-cells-therapeutics-market
Some key players operating in the market include Affimed N.V., Celgene Corp., Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics BV, and others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Affimed N.V., Celgene Corp., Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics BV.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Natural Killer Cells Therapeutics Market – Segmentation
By Therapeutics
- NK Cell Therapies
- NK Cell Directed Antibodies
By Application
- Cancer
- Gastrointestinal Disease
- Immunoproliferative Disorders
- Others
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
